Oura

Oura will fold Counsel Health's AI chat and on-call physicians into the Oura app, paired with ring data, after a $625 million cash deal expected to close by year end.

Oura has filed a new patent suit in Texas over the Ultrahuman Ring Pro, the ring Ultrahuman reworked after losing the Ring Air in the US. The Ring Pro is still on sale while the case runs.

Oura dropped the six-minute walking test: the ring now estimates VO2 max from five GPS walks, runs or hikes. A new Cardio Effort score adds up how hard your heart worked each week and tells you when to rest, on Gen3 rings and newer.

Oura delayed pricing on its Nasdaq offering hours before shares were set to trade, saying demand was strong but conditions were not.

Apple hasn't decided to ship it, and Bloomberg's reporting puts any release in 2028 at the earliest, so the Apple Watch stays Apple's only fitness wearable for years yet.

Oura set its IPO at 50 million shares for $40 to $44 each. Existing shareholders are selling 36.5 million of them.

Oura's prospectus says 94% of ring buyers take the subscription and the company made $60.8 million in nine months. It also expects future features to be regulated as medical devices.

Ten variants under one Brazilian certificate is a size range, and it puts Garmin's unannounced ring between the current Oura and the one before it.